Patricia E. Braga

Av. Vital Brasil, 1500, Butantã
Sao Paulo, SP 05503900, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine.

Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine.

Journal: Nature medicine

Published: August 12, 2025

Indirect protection and long-term effectiveness of inactivated COVID-19 vaccine: a stepped-wedge randomised trial in Serrana, Brazil.

Indirect protection and long-term effectiveness of inactivated COVID-19 vaccine: a stepped-wedge randomised trial in Serrana, Brazil.

Journal: Scientific reports

Published: June 18, 2025

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac) in Brazilian healthcare professionals: The PROFISCOV trial.

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac) in Brazilian healthcare professionals: The PROFISCOV trial.

Journal: Vaccine

Published: May 08, 2025

Long-term efficacy and immune response of CoronaVac in Brazilian health care workers: Insights from PROFISCOV unblinded trial.

Long-term efficacy and immune response of CoronaVac in Brazilian health care workers: Insights from PROFISCOV unblinded trial.

Journal: Vaccine

Published: July 18, 2024

Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/BioNTech) in immunocompromised and immunocompetent individuals.

Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/BioNTech) in immunocompromised and immunocompetent individuals.

Journal: Revista do Instituto de Medicina Tropical de Sao Paulo

Published: May 27, 2024

Evaluating the safety profile of the CoronaVac in adult and older adult populations: A phase IV prospective observational study in Brazil.

Evaluating the safety profile of the CoronaVac in adult and older adult populations: A phase IV prospective observational study in Brazil.

Journal: PLOS global public health

Published: April 18, 2024

Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil.

Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil.

Journal: The Lancet. Infectious diseases

Published: March 20, 2024

Effectiveness of CoronaVac in the prevention of COVID-19, a test-negative case-control study in Brazil.

Effectiveness of CoronaVac in the prevention of COVID-19, a test-negative case-control study in Brazil.

Journal: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Published: February 20, 2024

Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.

Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.

Journal: The New England journal of medicine

Published: January 31, 2024

School-based HPV vaccination program implementation in municipalities of the São Paulo State, Brazil, from 2015 to 2018.

School-based HPV vaccination program implementation in municipalities of the São Paulo State, Brazil, from 2015 to 2018.

Journal: Cadernos de saude publica

Published: July 11, 2023

Antibody response dynamics to CoronaVac vaccine and booster immunization in adults and the elderly: A long-term, longitudinal prospective study.

Antibody response dynamics to CoronaVac vaccine and booster immunization in adults and the elderly: A long-term, longitudinal prospective study.

Journal: IJID regions

Published: January 06, 2023

A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults.

A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults.

Journal: Vaccine

Published: December 08, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026